Related Experiment Videos
Interleukin-1 and interleukin-2 production by peripheral blood mononuclear cells in multiple sclerosis patients
K Selmaj1, Z Nowak, H Tchórzewski
1Department of Neurology, Medical Academy of Lodz, Poland.
Abstract:
The production of interleukin-1 (IL-1) and interleukin-2 (IL-2) by peripheral blood mononuclear cells (PBM) was assessed in multiple sclerosis (MS) patients in relapse, chronic progressive MS patients, patients with other neurological diseases (OND) and healthy subjects. Production was defined as the level of IL-1 and IL-2 in PBM supernatants. Neither spontaneous nor LPS-induced IL-1 production differed significantly in MS, OND patients or healthy individuals. On the other hand PHA-induced PBM IL-2 production was significantly less in MS patients in relapse (130 +/- 10.0 U/ml) than in chronic progressive MS patients (172 +/- 9.8 U/ml), OND patients (192 +/- 11.5 U/ml) and healthy subjects (215 +/- 13.8 U/ml) (P less than 0.02). Spontaneous IL-2 production was also diminished in MS patients in relapse (31 +/- 7.2 U/ml) as compared to chronic progressive MS patients (46 +/- 8.8 U/ml) and healthy subjects (49 +/- 11.1 U/ml) (P less than 0.01). Anti-Tac monoclonal antibody was used to study IL-2 receptor expression on the same sample of PBM that was used for IL-2 study. MS patients in relapse had significantly higher levels of IL-2 receptor-positive unstimulated PBM (6.0 +/- 2.2%) as compared to chronic progressive MS (2.0 +/- 0.9%), OND (2.5 +/- 1.1%) and healthy subjects (1.5 +/- 0.7%) (P less than 0.002). We postulate that reduced apparent IL-2 production by PBM of MS patients in relapse may result from immediate IL-2 binding to receptor expressed on activated T lymphocytes and internalization of IL-2-receptor complex.
Insights
Multiple sclerosis patients in relapse show reduced interleukin-2 (IL-2) production and increased IL-2 receptor expression in peripheral blood mononuclear cells (PBM). This suggests IL-2 may be rapidly consumed by activated T cells during relapse.
Area of Science:
- Immunology
- Neuroscience
Background:
- Multiple Sclerosis (MS) is a chronic neurological disease.
- Immune system dysregulation plays a role in MS pathogenesis.
- Interleukin-1 (IL-1) and Interleukin-2 (IL-2) are key cytokines in immune responses.
Purpose of the Study:
- To investigate the production of IL-1 and IL-2 by peripheral blood mononuclear cells (PBM) in patients with MS.
- To compare cytokine production in MS patients during relapse and remission with other neurological disease (OND) patients and healthy controls.
- To examine IL-2 receptor expression on PBM in these groups.
Main Methods:
- Peripheral blood mononuclear cells (PBM) were isolated from MS patients (relapse and chronic progressive), OND patients, and healthy subjects.
- IL-1 and IL-2 production was measured in PBM supernatants spontaneously and after stimulation (LPS for IL-1, PHA for IL-2).
- IL-2 receptor expression was assessed using the Anti-Tac monoclonal antibody on unstimulated PBM.
Main Results:
- IL-1 production was not significantly different across all groups.
- PHA-induced IL-2 production was significantly lower in MS patients during relapse compared to other groups.
- Spontaneous IL-2 production was also diminished in relapsing MS patients.
- IL-2 receptor-positive unstimulated PBM were significantly higher in relapsing MS patients.
Conclusions:
- Reduced apparent IL-2 production in relapsing MS may be due to rapid binding to upregulated IL-2 receptors on activated T lymphocytes.
- This suggests a potential mechanism involving IL-2-receptor complex internalization during MS relapse.
- Findings highlight altered T-cell activation and cytokine dynamics in active MS.